Inovio Pharmaceuticals, Inc. (AMEX:INO) reported Q1 EPS of ($0.05), $0.01 worse than the analyst estimate of ($0.04). Inovio Pharmaceuticals Inc. (NYSEMKT:INO) stock opened today at $2.19 and is currently trading at $2.00. The stock showed a negative weekly performance of -15.62%.
Amarin Co. plc (ADR) (NASDAQ:AMRN) posted its quarterly earnings results on Friday. The company reported ($0.16) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.18) by $0.02, Analyst Ratings Network.com reports. The company had revenue of $11.00 million for the quarter, compared to the consensus estimate of $11.65 million. Amarin Co. plc (ADR)’s revenue was up 378.3% compared to the same quarter last year. Amarin Corporation plc (ADR) (NASDAQ:AMRN) stock opened at $1.48, in current trading session and currently is at $1.47, by losing -2.65%. The 52 week range of $1.36 – $7.98. Company’s market capitalization is 254.14 million.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) declared that it would provide a corporate update and report first quarter 2014 financial results after the NASDAQ Global Select Market closes on Monday, May 12, 2014. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock is currently trading at $6.95. The EPS of the stock is -0.09. Company’s market capitalization is 1.52 billion.
U.S. drugmaker Allergan Inc (AGN.N) on Monday rejected Valeant Pharmaceuticals International Inc’s (VRX.TO) (NYSE:VRX) $47 billion takeover offer, saying the suitor’s proposed cost cuts were too steep. Valeant Pharmaceuticals Intl Inc. (NYSE:VRX) stock opened the session at $130.12, and now is at $129.06. The 52 week range of the Valeant Pharmaceuticals Intl Inc. (NYSE:VRX) stock remained $72.25 – $153.10 and the day range was $129.05 – $131.65.
GlaxoSmithKline plc (NYSE:GSK) and Theravance, Inc. announced that the European Commission has granted marketing authorisation for Anoro (umeclidinium/vilanterol) as a once-daily, maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD). GlaxoSmithKline plc (ADR) (NYSE:GSK) stock opened at $54.83, in current trading session and currently is at $54.82, by losing -0.31%. The 52 week range of $48.30 – $56.73. Company’s market capitalization is 133.19 billion.